GPR39 and epilepsy: Pharmacologic targeting of GPR39 may prove effective in disorders characterized by dysregulated neural circuits and neurotoxicity from hyperexcitability, with potential for modulating epilepsy, inflammation, pH dysregulation, chronic pain, and neuropsychiatric disorders.